DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer

News   Oct 03, 2017 | Original story from UCSD

 
DNA Mutations Shed in Blood Predicts Response to Immunotherapy in Patients with Cancer
 
 
 

RELATED ARTICLES

British Pharmacological Society’s Drug Discovery of the Year 2018 Announced

News

A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.

READ MORE

New Rapid Test for Valley Fever Should Help Reduce Diagnosis Delays

News

November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.

READ MORE

Inflammation Causes Chemo Brain

News

The research could lead to a new practice of identifying inflammatory biomarkers in cancer patients and then treating the inflammation with medications or exercise to improve cognition and other symptoms.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE